Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Blood Cells, Molecules & Diseases
|
September 14, 2007
CMV-specific T cell therapy
Hermann Einsele, Markus Kapp, Götz Ulrich Grigoleit
Current Opinion in Hematology
|
October 9, 2014
Diagnosis and treatment of cytomegalovirus 2013
Hermann Einsele, Stephan Mielke, Götz Ulrich Grigoleit
Current Opinion in Hematology
|
July 10, 2009
Cellular therapy to control tumor progression
Markus Kapp, Leo Rasche, Hermann Einsele, et al.
BMC Neurology
|
February 12, 2017
Case report: subacute tetraplegia in an immunocompromised patient
Daniel Zeller, Anke Heidemeier, Götz Ulrich Grigoleit, et al.
Best Practice & Research. Clinical Haematology
|
September 20, 2011
Adoptive immunotherapy with virus-specific T cells
Shigeo Fuji, Markus Kapp, Götz Ulrich Grigoleit, et al.
Clinical Transplantation
|
October 8, 2014
Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus
Mathias Lutz, Markus Kapp, Hermann Einsele, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 30, 2020
Quantification of letermovir in human serum using high-performance liquid chromatography with diode array detection
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 30, 2019
Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole
Verena Luber, Mathias Lutz, Marianne Abele-Horn, et al.
Journal of the Pediatric Infectious Diseases Society
|
April 25, 2020
Determination of Letermovir Serum Levels Can Be Useful in High-Risk Clinical Settings
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2021
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice-a prospective single-center trial
Nora Isberner, Sabrina Kraus, Götz Ulrich Grigoleit, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Blood Cells, Molecules & Diseases
|
September 14, 2007
CMV-specific T cell therapy
Hermann Einsele, Markus Kapp, Götz Ulrich Grigoleit
Current Opinion in Hematology
|
October 9, 2014
Diagnosis and treatment of cytomegalovirus 2013
Hermann Einsele, Stephan Mielke, Götz Ulrich Grigoleit
Current Opinion in Hematology
|
July 10, 2009
Cellular therapy to control tumor progression
Markus Kapp, Leo Rasche, Hermann Einsele, et al.
BMC Neurology
|
February 12, 2017
Case report: subacute tetraplegia in an immunocompromised patient
Daniel Zeller, Anke Heidemeier, Götz Ulrich Grigoleit, et al.
Best Practice & Research. Clinical Haematology
|
September 20, 2011
Adoptive immunotherapy with virus-specific T cells
Shigeo Fuji, Markus Kapp, Götz Ulrich Grigoleit, et al.
Clinical Transplantation
|
October 8, 2014
Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus
Mathias Lutz, Markus Kapp, Hermann Einsele, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 30, 2020
Quantification of letermovir in human serum using high-performance liquid chromatography with diode array detection
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 30, 2019
Excretion of Ascaris lumbricoides following reduced-intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole
Verena Luber, Mathias Lutz, Marianne Abele-Horn, et al.
Journal of the Pediatric Infectious Diseases Society
|
April 25, 2020
Determination of Letermovir Serum Levels Can Be Useful in High-Risk Clinical Settings
Nora Isberner, Fatemeh Aghai, Diana Schirmer, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2021
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice-a prospective single-center trial
Nora Isberner, Sabrina Kraus, Götz Ulrich Grigoleit, et al.
Page
of 4